-
Exemestane Workflows for Aromatase Research
2026-09-03
Build reproducible microsomal, cellular, and tissue workflows around Exemestane, an irreversible steroidal aromatase inhibitor designed to suppress estrogen formation. The guide emphasizes assay selection, washout-based confirmation of irreversible activity, matrix-specific controls, and practical troubleshooting for breast cancer research.
-
Dutasteride Workflows for Prostate Cell Research
2026-09-03
Build reproducible Dutasteride experiments around androgen conversion, cell growth, viability, and apoptosis rather than relying on a single endpoint. This practical workflow also shows how a hepatocyte–macrophage study can inspire better assay architecture without overstating cross-domain evidence.
-
Nav1.5 Ser571 Phosphorylation in Cardiac Aging
2026-09-02
The 2024 reference study identifies Nav1.5 phosphorylation at Ser571 as a mechanistic link between increased late sodium current, delayed ventricular repolarization, and impaired diastolic relaxation. By combining age-stratified wild-type mice with phosphomimetic and phosphoablated models, the work shows that late sodium current remodeling can anticipate or attenuate features of the aging myopathy, providing a framework for targeted cardiac electrophysiology studies.
-
Leupeptin Hemisulfate Salt: Practical Assays
2026-09-02
Leupeptin, Microbial supports controlled protease activity regulation, protein degradation studies, autophagy experiments, and model-specific viral replication inhibition. This workflow-focused guide combines fresh-solution handling, competitive enzyme assays, cell-based controls, and the binding-validation logic of a modern TET2 protocol.
-
CDK9 inhibitor A3294: Protocol and QC Guide
2026-09-01
CDK9 inhibitor A3294 is a selective serine/threonine kinase inhibitor for testing CDK9-dependent transcription elongation and exploratory HIV-1 propagation inhibition. It is suited to controlled biochemical and cellular workflows, but not to broad CDK inhibition, therapeutic conclusions, or long-term storage of prepared solutions.
-
Tunicamycin as a Context-Aware ER Stress Probe
2026-09-01
Tunicamycin is a powerful N-glycosylation inhibitor, but its experimental meaning depends on cell type, exposure, and rescue design. This guide connects glycosylation blockade to macrophage inflammation and splenic T-cell dysfunction while translating the evidence into better assay decisions.
-
Praeruptorin A: Applied Research Workflows
2026-08-31
Praeruptorin A is an angular pyranocoumarin compound suited to integrated ferroptosis, inflammation, barrier-function, cardiomyopathy, and metastasis workflows. This practical guide connects concentration selection, orthogonal readouts, formulation control, and troubleshooting for more reproducible preclinical experiments.
-
Perphenazine: From D2 Antagonism to Host Defense
2026-08-30
Perphenazine is a dopamine D2 receptor antagonist whose value extends from neuropharmacology into mechanistic host-defense research. This article develops an assay-centered framework connecting receptor pharmacology, mitochondrial stress, ROS, autophagy, and intracellular antibacterial activity.
-
OLIG2 mRNA for Rapid hiPSC Oligodendrocyte Differentiation
2026-08-29
Xu et al. developed a transgene-free strategy that uses repeated delivery of an OLIG2S147A synthetic modified messenger RNA to guide human induced pluripotent stem cells toward oligodendrocyte progenitor cells. The reference study established a six-day induction workflow that generated cultures containing more than 70% NG2-positive progenitors and demonstrated maturation and remyelination-related activity.
-
Phenothiazines Boost Macrophage Antibacterial Defense
2026-08-29
A 2025 Frontiers in Immunology study shows that phenothiazines strengthen macrophage control of intracellular bacteria by coordinating reactive oxygen species accumulation, lysosomal activity, and autophagy. The work positions perphenazine as a host-directed antibacterial lead while emphasizing that its immune mechanism should not be assumed to arise from dopamine receptor blockade.
-
ABT-888 (Veliparib) Workflow for DNA Repair Studies
2026-08-28
ABT-888 (Veliparib) provides a practical way to model PARP1/2-dependent DNA repair inhibition and test chemotherapy or radiation sensitization. This workflow emphasizes formulation control, genotype-aware assay design, and the context-specific limits revealed by recent acute leukemia screening data.
-
Chicken GSDME and RNA Virus-Induced Pyroptosis
2026-08-28
Chen et al. identify chicken Gasdermin E as a central pore-forming effector of RNA virus-induced pyroptosis, resolving a major question created by the absence of GSDMD in chickens. Their DF-1 cell experiments connect MDA5-dependent sensing with caspase-3/7 activation, cleavage of chGSDME at 270DAVD273, and reduced pyroptosis and viral release after chGSDME depletion.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-08-27
Oh et al. developed a scalable human induced pluripotent stem cell-derived sensory neuron system that reproduces major molecular features of HSV-1 latency and supports pharmacological reactivation. The model provides a human neuronal platform for studying viral chromatin control, neuron-intrinsic latency mechanisms, and candidate interventions.
-
Affordable GRO-seq Profiling in Bread Wheat
2026-08-27
This STAR Protocols study introduces an rRNA-depletion step that makes Global Run-On sequencing more efficient for profiling nascent transcription in allohexaploid bread wheat. The workflow improved the proportion of valid sequencing data by 20-fold in the authors’ application, providing a practical route for studying enhancer transcription in complex genomes.
-
iPSC Prescreening for Ultrarare Disease Trials
2026-08-26
Sequiera et al. developed a patient-specific iPSC platform to evaluate treatment candidates for an ultrarare Leigh-like syndrome caused by previously uncharacterized ECHS1 variants. The study shows how genotype-matched cellular models may reduce trial-and-error decisions by connecting drug screening with longitudinal clinical and metabolic assessment.